Health Ministry May Ban 2 Antibiotic Groups Carboxypenicillins, Phosphonic Acid Derivatives for Animal Use
New Delhi: The Union Health Ministry has published a draft notification proposing to prohibit the import, manufacture, sale, and distribution of carboxypenicillins and phosphonic acid derivatives and their formulations for animal use.
The draft has been issued under Section 26A of the Drugs and Cosmetics Act, 1940, after consultation with the Drugs Technical Advisory Board. It covers carboxypenicillins and phosphonic acid derivatives, along with their formulations, for animal use.
The draft has been issued under Section 26A of the Drugs and Cosmetics Act, 1940, after consultation with the Drugs Technical Advisory Board. It covers the following antimicrobials and their formulations for animal use:
- Carboxypenicillins
- Phosphonic acid derivatives
The ministry has invited objections and suggestions from persons who may be affected. The draft will be considered on or after 30 days from the date on which copies of the Gazette containing it are made available to the public. Objections and suggestions received within that period will be considered by the Central Government.
Submissions may be sent to the Under Secretary (Drugs), Ministry of Health and Family Welfare, Government of India, U-6, Work Hall–C Wing, First Floor, Kartavya Bhawan-1, New Delhi – 110001, or emailed to drugsdiv-mohfw@gov.in.
To view the official notice, click the link below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.